Photo of Usharbudh (U. Shivraj)  Sohur, MD, PhD

Usharbudh (U. Shivraj) Sohur, MD, PhD


Accepting New Patients




Clinical Interests
  • Movement disorders
  • Parkinson's and related parkinsonian disorders
  • Tremor; essential tremor; medication-related tremor
  • Complex neurological disorders
Medical Education
  • MD, Vanderbilt University School of Medicine
  • PhD, Vanderbilt University School of Medicine
  • Residency, Beth Israel Deaconess Medical Center
  • Fellowship, Massachusetts General Hospital
Board Certifications
  • Neurology
Foreign Languages
  • French
  • Urdu
  • Hindi
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group

Research & Publications

Research Summary

Parkinson's disease (PD) is currently an incurable, chronic and debilitating basal ganglia disorder, centrally due to the degeneration of midbrain dopaminergic neurons (mesDA) subtypes, with closely related types of neurons also implicated in secondary ways. The overarching hypothesis of this work is that understanding the molecular-genetic mechanisms of the precise initial development of mesDA subtypes will potentially contribute importantly in cellular replacement and circuit repair or modulation strategies of vulnerable circuitry. Identifying the molecular-genetic controls over subtype-specific generation and differentiation of such mesDA subtypes likely represents a critical step for the development of cellular replacement / circuit repair strategies in PD, since key developmental programs are re-initiated in the adult CNS upon neuronal loss.

In the laboratory, by using innovative approaches such as microsurgery in PD models, fluorescence activated cell sorting (FACS) and state of the art molecular neuroscience, Dr. Sohur and his group investigate how different populations of mesDA develop in the brain. By understanding the molecular mechanisms of the subtype specificity of mesDA with precision, it is hoped that, down the road, we will translate these findings to help our patients with PD.


View my most recent publications at PubMed


Neurology Associates
15 Parkman Street
Boston, MA 02114-3117
Phone: 617-726-5532

Back to Top